Juraleviciute et al. (2020) confirmed that MX2 downregulation promoted melanoma proliferation, as well as a high level of MX2 was linked to better patient survival, which proved that MX2 was a tumor suppressor gene by regulating the cell cycle in melanoma. This evidence concerns the gene MX2 and neoplasm.